Effects of a hydroalcoholic extract of Juglans regia (walnut) leaves on blood glucose and major cardiovascular risk factors in type 2 diabetic patients: A double-blind, placebo-controlled clinical trial

BMC Complementary and Alternative Medicine

Volumn 18, Issue 1, 2018, Pages

  Rabiei, Khadijeh ^a   Ebrahimzadeh, Mohammad Ali ^b   Saeedi, Majid ^b   Bahar, Adele ^c   Akha, Ozra ^c   Kashi, Zahra ^c,d  

^a Scientific Studies Institute of Nadali Esmaeili   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Avicel; Blood glucose; Blood pressure; Cardiovascular; Diabetes mellitus; Herbal medicine; Juglans regia; Microcrystalline cellulose; Walnut leaves; Weight

Indexed keywords

ANTIOXIDANT; GLUCOSE; HEMOGLOBIN A1C; JUGLANS REGIA EXTRACT; LIPID; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; METABOLISM; MIDDLE AGED; RISK FACTOR; VERY ELDERLY; WALNUT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JUGLANS; LIPIDS; MALE; MIDDLE AGED; PLANT EXTRACTS; PLANT LEAVES; RISK FACTORS;

EID: 85049511803     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-018-2268-8     Document Type: Article

References (28)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
2. Schmieder RE, Tschope D, Koch C, Ouarrak T, Gitt AK. Individualised treatment targets in patients with type-2 diabetes and hypertension. Cardiovasc Diabetol. 2018;17(1):18.
3. Kurukulasuriya LR, Sowers JR. Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors. Cardiovasc Diabetol. 2010;9:45.
4. Qureshi MN, Stecher G, Bonn GK. Determination of total polyphenolic compounds and flavonoids in Juglans regia leaves. Pak J Pharm Sci. 2014;27(4):865-9.
5. Bahramsoltani R, Ebrahimi F, Farzaei MH, Baratpourmoghaddam A, Ahmadi P, Rostamiasrabadi P, Rasouli Amirabadi AH, Rahimi R. Dietary polyphenols for atherosclerosis: a comprehensive review and future perspectives. Crit Rev Food Sci Nutr. 2017;11:1-19.
6. Rabiei K, Bekhradnia S, Nabavi SM, Nabavi SF, Ebrahimzadeh MA. Antioxidant activity of polyphenol and ultrasonic extracts from fruits of Crataegus pentagyna subsp. elburensis. Nat Prod Res. 2012;26(24):2353-7.
7. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16(1):77-84.
8. Naqinezhad A, Nabavi SM, Nabavi SF, Ebrahimzadeh MA. Antioxidant and antihemolytic activities of flavonoid rich fractions of Artemisia tschernieviana Besser. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 3):88-94.
9. Jelodar G, Mohsen M, Shahram S. Effect of walnut leaf, coriander and pomegranate on blood glucose and histopathology of pancreas of alloxan induced diabetic rats. Afr J Tradit Complement Altern Med. 2007;4(3):299-305.
10. Gholamreza K, Hossein B. Effects of walnut leaf aqueous extract on blood sugar and lipids in male diabetic rats. Saudi Med J. 2008;29(9):1350-2.
11. Asgary S, Parkhideh S, Solhpour A, Madani H, Mahzouni P, Rahimi P. Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats. J Med Food. 2008;11(3):533-8.
12. Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi S, Yousefi MH, Alimardani R, Jamshidi A, et al. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther. 2010;35(5):581-8.
13. Hosseini S, Huseini HF, Larijani B, Mohammad K, Najmizadeh A, Nourijelyani K, Jamshidi L. The hypoglycemic effect of Juglans regia leaves aqueous extract in diabetic patients: a first human trial. Daru. 2014;22(1):19.
14. Cui Y, Tao Y, Jiang L, Shen N, Wang S, Wen H, Liu Z. Antihypoxic activities of constituents from Arenaria kansuensis. Phytomedicine: Int J Phytotherapy and Phytopharmacology. 2018;38:175-82.
15. The United States Pharmacopeia (USP 39). In. USA. Baltimore: United Book Press Inc; 2016. p. 111-42.
16. Ghasemi K, Ghasemi Y, Ebrahimzadeh MA. Antioxidant activity, phenol and flavonoid contents of 13 citrus species peels and tissues. Pak J Pharm Sci. 2009;22(3):277-81.
17. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527-34.
18. Zargari A. Medical plants. Tehran: Tehran University Press; 1990.
19. Farzaei F, Morovati MR, Farjadmand F, Farzaei MH. A mechanistic review on medicinal plants used for diabetes mellitus in traditional Persian medicine. J Evid Based Complementary Altern Med. 2017;22(4):944-55.
20. Farzaei MH, Rahimi R, Farzaei F, Abdollahi M. Traditional medicinal herbs for the Management of Diabetes and its complications: an evidence-based review. Int J Pharmacol. 2015;11(7):14.
21. Kamyab H, Hejrati S, Khanavi M, Malihi F, Mohammadirad A, Baeeri M, Esmaily H, Abdollahi M. Hepatic mechanisms of the walnut antidiabetic effect in mice. Central Eur J Biol. 2010;5(3):304-9.
22. Abdoli M, Dabaghian FH, Goushegir A, Shirazi MT, Nakhjavani M, Shojaii A, Rezvani S, Mahlooji K. Anti-hyperglycemic effect of aqueous extract of Juglans regia L. leaf (walnut leaf) on type 2 diabetic patients: a randomized controlled trial. Advances in Integrative Med. 2017;4(3): 98-102.
23. Takahashi T, Karita S, Ogawa N, Goto M. Crystalline cellulose reduces plasma glucose concentrations and stimulates water absorption by increasing the digesta viscosity in rats. J Nutr. 2005;135(10):2405-10.
24. Arnaud M. Chronic venous disorders: pharmacological and clinical aspects of micronized purified flavonoid fraction. Phlebolymphology. 2016;23(2):8.
25. Rowe RC, Sheskey PJ, Quinn ME, Association AP. In: Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of pharmaceutical excipients. 6th ed. EDN England: London; Chicago: Washington, DC: Pharmaceutical Press; American Pharmacists Association; 2009.
26. Ma Y, Njike VY, Millet J, Dutta S, Doughty K, Treu JA, Katz DL. Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care. 2010;33(2):227-32.
27. Rock CL, Flatt SW, Barkai HS, Pakiz B, Heath DD. Walnut consumption in a weight reduction intervention: effects on body weight, biological measures, blood pressure and satiety. Nutr J. 2017;16(1):76.
28. Gale EAM, Gillespie KM. Diabetes and gender. Diabetologia. 2001;44(1):3-15.